Desmoteplase
Recombinant proteinexperimental
Clinical trial activity
6 trials · 5 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
6
Phase 3
3
Phase 4
0
Earliest trial started Mar 1, 2001 (NCT00638781)
Timeline
Indications
Studied for
Mechanism of action
- PlasminogenACTIVATOR
PLG activator
Fibrin-selective.
Chemistry & pharmacology
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
- Multi-specific
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL2109084 ↗
Also known as
- desmodus rotundus salivary plasminogen activator
- desmodus salivary plasminogen activator
- desmoteplase
- desmoteplase
- desmoteplase
- desmoteplase
- dspa
- dspa
- dspa alpha 1 protein, desmodus rotundus
- rdspa alpha 1
- salivary plasminogen activator alpha 1, desmodus rotundus
- salivary plasminogen activator, vampire bat
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01104467 | Phase 2 | Aug 1, 2010 | Lundbeck |
| NCT00856661 | Phase 3 | Apr 1, 2009 | Lundbeck |
| NCT00790920 | Phase 3 | Dec 1, 2008 | Lundbeck |
| NCT00111852 | Phase 3 | Apr 1, 2005 | Forest Laboratories |
| NCT00638248 | Phase 1/Phase 2 (Phase 2) | Mar 1, 2003 | PAION Deutschland GmbH, University of Rochester |
| NCT00638781 | Phase 2 | Mar 1, 2001 | PAION Deutschland GmbH, University of Heidelberg |
Showing 6 of 6 trials
Page 1 / 1
Organizations
Research & Development (5)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Lundbeck | For profit | 3 | 3 | 2 | 2008 |
| PAION Deutschland GmbH | For profit | 2 | 2 | 1 | 2001 |
| Forest Laboratories | For profit | 1 | 1 | 1 | 2005 |
| University of Heidelberg | Academic/Hospital | 1 | 0 | 1 | 2001 |
| University of Rochester | Academic/Hospital | 1 | 0 | 1 | 2003 |
5 organizations
Page 1 / 1